Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil.

× No keyword cloud information.

50 in total

1. In vitro enhancement of fluoropyrimidine-induced cytotoxicity by leucovorin in colorectal and gastric carcinoma cell lines but not in non-small-cell lung carcinoma cell lines.

Authors: Y Sugimoto; Y Ohe; K Nishio; T Ohmori; Y Fujiwara; N Saijo
Journal: Cancer Chemother Pharmacol Date: 1992 Impact factor: 3.333

2. Inhibition of thymidylate synthase by the diastereoisomers of leucovorin.

Authors: P P Lee; R L Schilsky
Journal: Cancer Chemother Pharmacol Date: 1990 Impact factor: 3.333

3. Intraarterial hepatic chemotherapy with fluorouracil, fluorodeoxyuridine, mitomycin C, cisplatin or methotrexate as single-agent anticancer drugs for a transplanted experimental liver tumor in rats.

Authors: S Kurth; D Bulian; B Kreft; T Riemenschneider
Journal: J Cancer Res Clin Oncol Date: 1996 Impact factor: 4.553

Review 4. How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer.

Authors: P Ragnhammar; H Blomgren
Journal: Med Oncol Date: 1995-09 Impact factor: 3.064

Review 5. Drug treatment of colorectal cancer. Current status.

Authors: L Saltz
Journal: Drugs Date: 1991-10 Impact factor: 9.546

6. Effect of cisplatin in advanced colorectal cancer resistant to 5-fluorouracil plus (S)-leucovorin.

Authors: A Cassano; C Pozzo; D C Corsi; T Fontana; M R Noviello; A Astone; C Barone
Journal: J Cancer Res Clin Oncol Date: 1995 Impact factor: 4.553

7. Phase I clinical trial of cisplatin given i.v. with 5-fluorouracil and high-dose folinic acid.

Authors: J L Abbruzzese; R Amato; S Schmidt; M N Raber; P Frost
Journal: Cancer Chemother Pharmacol Date: 1990 Impact factor: 3.333

Review 8. Cellular pharmacology of fluorinated pyrimidines in vivo in man.

Authors: J S Kovach; R W Beart
Journal: Invest New Drugs Date: 1989-04 Impact factor: 3.850

9. A phase II pilot study of high-dose 24-hour continuous infusion of 5-FU and leucovorin and low-dose PALA for patients with colorectal cancer: a Southwest Oncology Group study.

Authors: Robert P Whitehead; Jacqueline K Benedetti; James L Abbruzzese; Bach Ardalan; Stephen Williamson; Ellen R Gaynor; Stanley P Balcerzak; John S Macdonald
Journal: Invest New Drugs Date: 2004-11 Impact factor: 3.850

10. Pharmacokinetics of rac-leucovorin vs [S]-leucovorin in patients with advanced gastrointestinal cancer.

Authors: R M Mader; G G Steger; B Rizovski; A E Sieder; G Locker; M F Gnant; R Jakesz; H Rainer
Journal: Br J Clin Pharmacol Date: 1994-03 Impact factor: 4.335